AMNCB yields 50000.00% · PFE yields 6.13%● Live data
📍 AMNCB pulled ahead of the other in Year 1
Combined, AMNCB + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AMNCB + PFE for your $10,000?
Amincor, Inc., through its subsidiaries, manufactures and sells bakery food products. It provides various sliced bread, yeast and cake doughnuts, frozen donuts, cookies, and snack products to supermarket "in-store" bakery departments, and food service channels. It also offers water remediation services, such as water testing and evaluation, system engineering and design, system training servicing, and maintenance service in the northeast United States, as well as is involved in treating and discharging petroleum impacted water into the sanitary sewer system. The company serves oil companies, petroleum marketers, jobbers, municipal entities, school districts, industrial facilities, and other businesses. In addition, it provides maintenance, repair, and construction services to customers with underground petroleum storage tanks and petroleum product dispensing equipment, as well as is engaged in environmental consulting, site assessment, analysis, and management of site remediation for owners and operators of petroleum storage facilities. The company serves national and multinational enterprises, as well as to local and national governmental agencies and municipalities. The company was formerly known as Joning Corp and changed its name to Amincor, Inc. in February 2010. Amincor, Inc. was incorporated in 1997 and is headquartered in New York, New York.
Full AMNCB Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.